ENDRA Life Sciences Inc. (NDRA)

USD 4.62

(0.87%)

Gross Profit Summary of ENDRA Life Sciences Inc.

  • ENDRA Life Sciences Inc.'s latest annual gross profit in 2023 was -275.45 Thousand USD , down -17.58% from previous year.
  • ENDRA Life Sciences Inc.'s latest quarterly gross profit in 2024 Q2 was -50.12 Thousand USD , up 9.97% from previous quarter.
  • ENDRA Life Sciences Inc. reported a annual gross profit of -234.25 Thousand USD in annual gross profit 2022, down -4.39% from previous year.
  • ENDRA Life Sciences Inc. reported a annual gross profit of -224.41 Thousand USD in annual gross profit 2021, down -35.8% from previous year.
  • ENDRA Life Sciences Inc. reported a quarterly gross profit of -55.67 Thousand USD for 2024 Q1, down -115.16% from previous quarter.
  • ENDRA Life Sciences Inc. reported a quarterly gross profit of -275.45 Thousand USD for 2023 FY, down -17.58% from previous quarter.

Annual Gross Profit Chart of ENDRA Life Sciences Inc. (2023 - 2014)

Historical Annual Gross Profit of ENDRA Life Sciences Inc. (2023 - 2014)

Year Gross Profit Gross Profit Growth
2023 -275.45 Thousand USD -17.58%
2022 -234.25 Thousand USD -4.39%
2021 -224.41 Thousand USD -35.8%
2020 -165.24 Thousand USD -43.68%
2019 -115.01 Thousand USD -1962.83%
2018 6174.00 USD -96.55%
2017 178.84 Thousand USD -36.06%
2016 279.7 Thousand USD -62.4%
2015 743.83 Thousand USD 147.77%
2014 300.21 Thousand USD 0.0%

Peer Gross Profit Comparison of ENDRA Life Sciences Inc.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD 102.879%
Prenetics Global Limited 8.82 Million USD 103.12%
Star Equity Holdings, Inc. 11.92 Million USD 102.31%
CareDx, Inc 178.32 Million USD 100.154%
Exact Sciences Corporation 1.84 Billion USD 100.015%
Exagen Inc. 29.45 Million USD 100.935%
Inotiv, Inc. 165.44 Million USD 100.166%
Guardant Health, Inc. 336.89 Million USD 100.082%
Biodesix, Inc. 36.07 Million USD 100.764%
BioNexus Gene Lab Corp. 1.32 Million USD 120.718%
Precipio, Inc. 6.01 Million USD 104.577%
iSpecimen Inc. 5.1 Million USD 105.393%
Natera, Inc. 492.74 Million USD 100.056%
Aspira Women's Health Inc. 5.26 Million USD 105.235%
Standard BioTools Inc. 50.45 Million USD 100.546%
23andMe Holding Co. 99.37 Million USD 100.277%
Castle Biosciences, Inc. 174.8 Million USD 100.158%
Personalis, Inc. 18.2 Million USD 101.513%
Aclaris Therapeutics, Inc. 13.16 Million USD 102.092%
Applied DNA Sciences, Inc. 5.53 Million USD 104.978%
OpGen, Inc. -90.69 Thousand USD -203.715%
T2 Biosystems, Inc. -8.17 Million USD 96.629%
Myriad Genetics, Inc. 476.4 Million USD 100.058%
ICON Public Limited Company 1.81 Billion USD 100.015%
NeoGenomics, Inc. 244.6 Million USD 100.113%
Star Equity Holdings, Inc. 11.92 Million USD 102.31%
IDEXX Laboratories, Inc. 2.18 Billion USD 100.013%
RadNet, Inc. 93 Million USD 100.296%
MDxHealth SA 43.92 Million USD 100.627%
Psychemedics Corporation 8.41 Million USD 103.274%
Illumina, Inc. 2.74 Billion USD 100.01%
Check-Cap Ltd. -212 Thousand USD -29.93%
Twist Bioscience Corporation 133.34 Million USD 100.207%
DarioHealth Corp. 5.98 Million USD 104.603%
Fulgent Genetics, Inc. 104.45 Million USD 100.264%
Sera Prognostics, Inc. 96 Thousand USD 386.928%
OPKO Health, Inc. 318.12 Million USD 100.087%
Medpace Holdings, Inc. 524.5 Million USD 100.053%
Neogen Corporation 463.9 Million USD 100.059%
Intelligent Bio Solutions Inc. 1.42 Million USD 119.321%
Prenetics Global Limited 8.82 Million USD 103.12%
Mainz Biomed B.V. 509.65 Thousand USD 154.046%
bioAffinity Technologies, Inc. 791.61 Thousand USD 134.796%
Trinity Biotech plc 19.45 Million USD 101.416%
Neuronetics, Inc. 51.7 Million USD 100.533%
Sotera Health Company 577.15 Million USD 100.048%
bioAffinity Technologies, Inc. 791.61 Thousand USD 134.796%